×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

ANI Pharmaceuticals Inc. (ANIP) NASDAQ

$64.60 (0.88) (-1.34%)

Market Cap: $1.37B

As of 04/18/24 03:59 PM EDT. Market closed.

(ANIP)

ANI Pharmaceuticals Inc. (ANIP)
NASDAQ

$64.60
(0.88) (-1.34%)

Market Cap: $1.37B

As of 04/18/24 03:59 PM EDT. Market closed.

Add to Portfolio

ani pharmaceuticals is an integrated specialty pharmaceutical company focused on delivering value to our customers by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceuticals. we focus on niche and high barrier to entry opportunities including controlled substances, anti-cancer (oncolytics), hormones and steroids, and complex formulations. our two ... read more

ani pharmaceuticals is an integrated specialty pharmaceutical company focused on delivering value to our customers by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceuticals. we focus on niche and high barrier to entry opportunities including controlled substances, anti-cancer (oncolytics), hormones and steroids, and complex formulations. our two pharmaceutical manufacturing facilities located in baudette, minnesota are capable of producing oral solid dose products, as well as liquids and topicals, controlled substances, and potent products that must be manufactured in a fully-contained environment. our objective is to create long term shareholder value by building a sustainable and growing base business in generic and mature brand pharmaceutical products while advancing an opportunity to re-commercialize cortrophin gel and cortrophin-zinc. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
CEO
Patrick Walsh
Full Time Employees
280
CEO Compensation (Base)
$726,925
CEO Compensation (Total)
$4.20M
URL
Address
210 W Main St, Minnesota, Baudette, 56623-2467.
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
CEO
Patrick Walsh
Full Time Employees
280
CEO Compensation (Base)
$726,925
CEO Compensation (Total)
$4.20M
Address
210 W Main St, Minnesota, Baudette, 56623-2467.
PRICE CHART FOR ANI PHARMACEUTICALS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$65.76
Previous Close
$65.48
Days Range
$65.02 - $66.06
52 week range
$36.99 - $70.50
Volume
184,179
Avg. Volume (30 days)
148,717
Market Cap
$1.37B
Dividend Yield
-
P/E
80.09
Shares Outstanding
20,980,307
Open
$65.76
Previous Close
$65.48
Days Range
$65.02 - $66.06
52 week range
$36.99 - $70.50
Volume
184,179
Avg. Volume (30 days)
148,717
Market Cap
$1.37B
Dividend Yield
-
P/E
80.09
Shares Outstanding
20,980,307
FINANCIAL STATEMENTS FOR ANI PHARMACEUTICALS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR ANI PHARMACEUTICALS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSApr 16, 2024 Sale$66.205,834386,211819,372Apr 17, 2024, 04:33 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSApr 15, 2024 Sale$66.337,414491,771825,206Apr 17, 2024, 04:33 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSApr 17, 2024 Sale$65.409,520622,608809,852Apr 17, 2024, 04:33 PM
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.Apr 12, 2024 Sale$67.7925016,94859,731Apr 15, 2024, 06:28 PM
Marken James G.SVP OPS & PROD DEVApr 10, 2024 Option Exercise$66.962,799187,421116,006Apr 11, 2024, 09:13 PM
CAREY STEPHEN P.SVP & CFOApr 10, 2024 Option Exercise$66.964,534303,597166,968Apr 11, 2024, 09:12 PM
Gassert ChadSVP - CORP. DEV. & STRATEGYApr 01, 2024 Sale$67.2520,0001,345,000253,226Apr 02, 2024, 06:59 PM
CAREY STEPHEN P.SVP & CFOMar 23, 2024 Option Exercise$69.586,210432,092171,502Mar 25, 2024, 04:17 PM
Marken James G.SVP OPS & PROD DEVMar 23, 2024 Option Exercise$69.583,653254,176118,805Mar 25, 2024, 04:14 PM
Lalwani NikhilPRESIDENT & CEOMar 23, 2024 Option Exercise$69.5817,4551,214,519394,174Mar 25, 2024, 04:09 PM
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.Mar 13, 2024 Sale$66.5425016,63559,981Mar 13, 2024, 04:48 PM
Gassert ChadSVP - CORP. DEV. & STRATEGYMar 11, 2024 Sale$65.8120,0001,316,200273,226Mar 13, 2024, 04:44 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSMar 08, 2024 Sale$67.1710,000671,700832,620Mar 11, 2024, 06:43 PM
CAREY STEPHEN P.SVP & CFOMar 07, 2024 Option Exercise$66.714,216281,249185,499Mar 11, 2024, 06:39 PM
CAREY STEPHEN P.SVP & CFOMar 11, 2024 Sale$65.557,787510,438177,712Mar 11, 2024, 06:39 PM
Lalwani NikhilPRESIDENT & CEOMar 07, 2024 Option Exercise$66.7117,0601,138,073427,921Mar 08, 2024, 07:25 PM
Lalwani NikhilPRESIDENT & CEOMar 08, 2024 Sale$67.1316,2921,093,682411,629Mar 08, 2024, 07:25 PM
Lalwani NikhilPRESIDENT & CEOMar 06, 2024 Sale$65.5228,9651,897,787444,981Mar 08, 2024, 07:25 PM
Marken James G.SVP OPS & PROD DEVMar 07, 2024 Option Exercise$66.712,034135,688122,458Mar 07, 2024, 09:42 PM
Marken James G.SVP OPS & PROD DEVMar 07, 2024 Sale$66.3724,3381,615,313124,492Mar 07, 2024, 09:42 PM
Gutwerg OriSVP, GENERICSMar 07, 2024 Option Exercise$66.712,494166,37580,212Mar 07, 2024, 09:21 PM
Mutz ChristopherHEAD OF RARE DISEASEMar 07, 2024 Option Exercise$66.712,110140,75885,277Mar 07, 2024, 09:16 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSMar 07, 2024 Sale$66.3515,0851,000,890842,620Mar 07, 2024, 09:11 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSMar 06, 2024 Sale$65.4714,822970,396857,705Mar 07, 2024, 09:11 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSMar 05, 2024 Sale$65.3510,093659,578872,527Mar 07, 2024, 09:11 PM
Mutz ChristopherHEAD OF RARE DISEASEMar 05, 2024 Sale$66.005,000330,00087,387Mar 06, 2024, 04:24 PM
Pera Antonio RDirectorMar 04, 2024 Sale$65.207,000456,40026,627Mar 06, 2024, 04:20 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSFeb 29, 2024 Option Exercise$67.671,12275,92668,652Mar 01, 2024, 05:18 PM
Mutz ChristopherHEAD OF RARE DISEASEFeb 29, 2024 Option Exercise$67.671,27586,27992,387Mar 01, 2024, 05:12 PM
Marken James G.SVP OPS & PROD DEVFeb 29, 2024 Option Exercise$67.671,05871,595148,830Mar 01, 2024, 05:09 PM
Lalwani NikhilPRESIDENT & CEOFeb 29, 2024 Option Exercise$67.6710,014677,647473,946Mar 01, 2024, 05:06 PM
Gutwerg OriSVP, GENERICSFeb 29, 2024 Option Exercise$67.671,570106,24282,706Mar 01, 2024, 05:03 PM
Gassert ChadSVP - CORP. DEV. & STRATEGYFeb 29, 2024 Option Exercise$67.671,635110,64049,679Mar 01, 2024, 05:01 PM
Davis KristaSVP, CHIEF HR OFFICERFeb 29, 2024 Option Exercise$67.671,17379,37751,545Mar 01, 2024, 04:59 PM
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.Feb 29, 2024 Option Exercise$67.671,17379,37760,231Mar 01, 2024, 04:57 PM
CAREY STEPHEN P.SVP & CFOFeb 29, 2024 Option Exercise$67.671,914129,520189,715Mar 01, 2024, 04:55 PM
Gutwerg OriSVP, GENERICSFeb 15, 2024 Option Exercise$57.551,24471,59284,276Feb 20, 2024, 05:09 PM
Mutz ChristopherHEAD OF RARE DISEASEFeb 15, 2024 Option Exercise$57.551,26172,57193,662Feb 20, 2024, 05:02 PM
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.Feb 13, 2024 Sale$56.0425014,01036,799Feb 13, 2024, 08:05 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSJan 23, 2024 Sale$56.4415,000846,600882,620Jan 23, 2024, 05:32 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSJan 22, 2024 Sale$55.955,692318,467897,620Jan 23, 2024, 05:32 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSJan 19, 2024 Sale$55.574,524251,399903,312Jan 23, 2024, 05:32 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSJan 18, 2024 Sale$55.309,784541,055907,836Jan 18, 2024, 06:20 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSJan 17, 2024 Sale$55.1110,000551,100917,620Jan 18, 2024, 06:20 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSJan 16, 2024 Sale$55.635,000278,150927,620Jan 18, 2024, 06:20 PM
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.Jan 12, 2024 Sale$56.4325014,10837,049Jan 16, 2024, 09:09 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSDec 19, 2023 Sale$52.6525,0001,316,250932,620Dec 19, 2023, 05:44 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSDec 18, 2023 Sale$52.4413,026683,083957,620Dec 19, 2023, 05:44 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSDec 15, 2023 Sale$52.4411,974627,917970,646Dec 19, 2023, 05:44 PM
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.Dec 11, 2023 Sale$49.2125012,30237,299Dec 11, 2023, 05:49 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSNov 17, 2023 Sale$51.0013,000663,000982,620Nov 20, 2023, 09:05 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSNov 15, 2023 Sale$53.647,647410,1851,002,068Nov 20, 2023, 08:58 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSNov 14, 2023 Sale$53.1722,9051,217,8591,009,715Nov 20, 2023, 08:58 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSNov 16, 2023 Sale$51.666,448333,104995,620Nov 20, 2023, 08:58 PM
Davis KristaSVP, CHIEF HR OFFICERNov 15, 2023 Sale$53.812,622141,09032,587Nov 16, 2023, 06:13 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSNov 16, 2023 Sale$51.666,448333,104996,430Nov 16, 2023, 06:11 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSNov 15, 2023 Sale$53.647,647410,1851,002,878Nov 16, 2023, 06:11 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSNov 14, 2023 Sale$53.1722,0951,174,7911,010,525Nov 16, 2023, 06:11 PM
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.Nov 13, 2023 Sale$52.0325013,00737,549Nov 14, 2023, 05:04 PM
Mutz ChristopherHEAD OF RARE DISEASENov 10, 2023 Sale$52.473,000157,41063,607Nov 13, 2023, 04:02 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSOct 19, 2023 Sale$57.0610,000570,6001,032,620Oct 19, 2023, 04:28 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSOct 18, 2023 Sale$57.786,242360,6631,042,620Oct 19, 2023, 04:28 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSOct 17, 2023 Sale$58.538,758512,6061,048,862Oct 19, 2023, 04:28 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSOct 16, 2023 Sale$58.3113,063761,7041,057,620Oct 17, 2023, 04:32 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSOct 13, 2023 Sale$57.5811,937687,3321,070,683Oct 17, 2023, 04:32 PM
Gassert ChadSVP - CORP. DEV. & STRATEGYOct 02, 2023 Sale$56.4820,0001,129,600293,226Oct 03, 2023, 08:00 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSSep 19, 2023 Sale$61.2325,3331,551,1401,082,620Sep 19, 2023, 05:14 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSSep 18, 2023 Sale$61.648,425519,3171,107,953Sep 19, 2023, 05:14 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSSep 15, 2023 Sale$62.8116,2421,020,1601,116,378Sep 19, 2023, 05:14 PM
Davis KristaSVP, CHIEF HR OFFICERSep 12, 2023 Option Exercise$61.911,48691,99835,209Sep 14, 2023, 08:01 AM
Lalwani NikhilPRESIDENT & CEOSep 08, 2023 Option Exercise$61.943,646225,833349,744Sep 11, 2023, 06:23 PM
Gassert ChadSVP - CORP. DEV. & STRATEGYSep 01, 2023 Sale$64.7020,0001,294,000313,226Sep 05, 2023, 05:06 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSAug 29, 2023 Sale$63.3725,0001,584,2501,132,620Aug 30, 2023, 04:29 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSAug 28, 2023 Sale$63.0625,0001,576,5001,157,620Aug 30, 2023, 04:29 PM
Gutwerg OriSVP, GENERICSAug 23, 2023 Option Exercise$31.4913,502425,17876,476Aug 25, 2023, 04:22 PM
Gutwerg OriSVP, GENERICSAug 23, 2023 Sale$62.3915,561970,85162,974Aug 25, 2023, 04:22 PM
Marken James G.SVP OPS & PROD DEVAug 23, 2023 Option Exercise$38.255,417207,224137,044Aug 25, 2023, 04:17 PM
Marken James G.SVP OPS & PROD DEVAug 23, 2023 Sale$63.003,932247,716133,112Aug 25, 2023, 04:17 PM
MERIDIAN VENTURE PARTNERS II LP10% OwnerAug 16, 2023 Sale$58.50200,00011,700,0001,819,259Aug 16, 2023, 08:00 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSAug 15, 2023 Sale$61.6022,1101,361,9761,182,620Aug 16, 2023, 07:07 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSAug 14, 2023 Sale$61.1527,8901,705,4741,204,730Aug 16, 2023, 07:07 PM
CAREY STEPHEN P.SVP & CFOAug 14, 2023 Sale$61.3717,6391,082,505155,839Aug 16, 2023, 04:24 PM
Pera Antonio RDirectorAug 14, 2023 Sale$60.373,000181,11033,627Aug 15, 2023, 08:45 PM
Lalwani NikhilPRESIDENT & CEOAug 15, 2023 Option Exercise$29.0011,616336,864365,006Aug 15, 2023, 08:39 PM
Lalwani NikhilPRESIDENT & CEOAug 11, 2023 Sale$57.7556,6663,272,462353,390Aug 15, 2023, 08:39 PM
Lalwani NikhilPRESIDENT & CEOAug 15, 2023 Sale$61.1311,616710,086353,390Aug 15, 2023, 08:39 PM
Gassert ChadSVP - CORP. DEV. & STRATEGYAug 01, 2023 Sale$51.0620,0001,021,200333,226Aug 03, 2023, 06:03 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSJul 21, 2023 Sale$52.5611,500604,4401,232,620Jul 21, 2023, 07:15 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSJul 20, 2023 Sale$51.526,000309,1201,244,120Jul 21, 2023, 07:15 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSJul 19, 2023 Sale$51.485,969307,2841,250,120Jul 21, 2023, 07:15 PM
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.Jul 18, 2023 Option Exercise$51.891,74390,44437,799Jul 19, 2023, 07:14 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSJul 18, 2023 Sale$51.846,700347,3281,256,089Jul 18, 2023, 08:06 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSJul 17, 2023 Sale$51.069,831501,9711,262,789Jul 18, 2023, 08:06 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSJul 14, 2023 Sale$50.4310,000504,3001,272,620Jul 18, 2023, 08:06 PM
Gassert ChadSVP - CORP. DEV. & STRATEGYJul 03, 2023 Sale$53.4320,0001,068,600353,226Jul 06, 2023, 04:15 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSJun 21, 2023 Sale$51.9511,843615,2441,306,120Jun 23, 2023, 08:01 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSJun 20, 2023 Sale$51.9314,657761,1381,317,963Jun 23, 2023, 08:01 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSJun 23, 2023 Sale$51.4910,000514,9001,282,620Jun 23, 2023, 08:01 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSJun 22, 2023 Sale$51.3813,500693,6301,292,620Jun 23, 2023, 08:01 PM
Gassert ChadSVP - CORP. DEV. & STRATEGYJun 22, 2023 Sale$51.3220,0001,026,400373,226Jun 23, 2023, 08:00 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSJun 22, 2023 Sale$51.3813,500693,6307,407Jun 22, 2023, 08:00 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSJun 21, 2023 Sale$51.9511,843615,24420,907Jun 22, 2023, 08:00 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSJun 20, 2023 Sale$51.9314,657761,13832,750Jun 22, 2023, 08:00 PM
CAREY STEPHEN P.SVP & CFOApr 10, 2023 Option Exercise$38.504,534174,559173,478Apr 12, 2023, 04:43 PM
Marken James G.SVP OPS & PROD DEVApr 10, 2023 Option Exercise$38.502,28988,127131,627Apr 12, 2023, 04:42 PM
Marken James G.SVP OPS & PROD DEVMar 28, 2023 Option Exercise$38.6252420,237112,206Mar 30, 2023, 08:01 PM
CAREY STEPHEN P.SVP AND CFOMar 28, 2023 Option Exercise$38.621,42054,840137,486Mar 30, 2023, 08:00 PM
Marken James G.SVP OPS & PROD DEVMar 23, 2023 Option Exercise$37.822,45292,735112,730Mar 27, 2023, 08:02 PM
Lalwani NikhilPRESIDENT & CEOMar 23, 2023 Option Exercise$37.8217,455660,148250,840Mar 27, 2023, 08:01 PM
CAREY STEPHEN P.SVP AND CFOMar 23, 2023 Option Exercise$37.824,224159,752138,906Mar 27, 2023, 08:00 PM
Mutz ChristopherHEAD OF RARE DISEASEMar 07, 2023 Option Exercise$44.231,90284,12538,136Mar 09, 2023, 06:48 PM
Gutwerg OriSVP, GENERICSMar 07, 2023 Option Exercise$44.232,342103,58734,613Mar 09, 2023, 06:46 PM
CAREY STEPHEN P.SVP AND CFOMar 07, 2023 Option Exercise$44.233,503154,938143,994Mar 09, 2023, 06:45 PM
Lalwani NikhilPRESIDENT & CEOMar 07, 2023 Option Exercise$44.2313,662604,270272,560Mar 09, 2023, 06:44 PM
Marken James G.SVP OPS & PROD DEVMar 07, 2023 Option Exercise$44.232,460108,806115,691Mar 09, 2023, 04:36 PM
Mutz ChristopherHEAD OF RARE DISEASEFeb 15, 2023 Option Exercise$45.041,29258,19239,562Feb 17, 2023, 04:32 PM
Gutwerg OriSVP, GENERICSFeb 15, 2023 Option Exercise$45.041,27557,42636,369Feb 17, 2023, 04:31 PM
MERIDIAN VENTURE PARTNERS II LP10% OwnerDec 01, 2022 Sale$38.50200,0007,700,0002,019,259Dec 02, 2022, 04:00 PM
Lalwani NikhilPRESIDENT & CEOSep 08, 2022 Option Exercise$37.613,646137,126281,957Sep 12, 2022, 08:15 PM
Marken James G.SVP OPS & PROD DEVAug 15, 2022 Sale$37.795,172195,464117,642Aug 16, 2022, 09:01 PM
Marken James G.SVP OPS & PROD DEVAug 12, 2022 Sale$37.0412,894477,605122,814Aug 16, 2022, 09:01 PM
Marken James G.SVP OPS & PROD DEVApr 10, 2022 Option Exercise$29.911,87856,171129,064Apr 12, 2022, 05:13 PM
CAREY STEPHEN P.SENIOR VICE PRESIDENT AND CFOApr 10, 2022 Option Exercise$29.914,534135,612135,342Apr 12, 2022, 05:11 PM
CAREY STEPHEN P.SENIOR VICE PRESIDENT AND CFOApr 06, 2022 Option Exercise$29.6991227,077139,876Apr 08, 2022, 05:37 PM
Marken James G.SVP OPS & PROD DEVApr 06, 2022 Option Exercise$29.6933710,006130,942Apr 08, 2022, 05:36 PM
Marken James G.SVP OPS & PROD DEVMar 28, 2022 Option Exercise$28.1752414,761131,279Mar 30, 2022, 04:13 PM
CAREY STEPHEN P.SENIOR VICE PRESIDENT AND CFOMar 28, 2022 Option Exercise$28.171,42040,001140,788Mar 30, 2022, 04:10 PM
Marken James G.SVP OPS & PROD DEVMar 23, 2022 Option Exercise$27.032,45266,278111,869Mar 25, 2022, 08:56 PM
CAREY STEPHEN P.SENIOR VICE PRESIDENT AND CFOMar 23, 2022 Option Exercise$27.034,167112,634108,333Mar 25, 2022, 08:53 PM
Lalwani NikhilPRESIDENT & CEOMar 23, 2022 Option Exercise$27.0317,454471,782152,196Mar 25, 2022, 08:52 PM
Lalwani NikhilPRESIDENT & CEOMar 21, 2022 Buy$27.697,224199,997169,650Mar 23, 2022, 09:05 PM
Walsh Patrick DDirectorMar 21, 2022 Buy$27.765,000138,79453,388Mar 22, 2022, 05:39 PM
Gassert ChadSVP - CORP. DEV. & STRATEGYMar 21, 2022 Buy$27.875,000139,342393,226Mar 22, 2022, 05:37 PM
Gassert ChadSVP - CORP. DEV. & STRATEGYMar 18, 2022 Buy$27.155,000135,744388,226Mar 22, 2022, 05:37 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSMar 17, 2022 Buy$27.655,000138,2515,000Mar 21, 2022, 09:58 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSMar 17, 2022 Buy$27.655,000138,25118,460Mar 21, 2022, 09:58 PM
Mutz ChristopherHEAD OF RARE DISEASEFeb 15, 2022 Option Exercise$40.251,18447,65614,950Feb 17, 2022, 07:24 PM
Gutwerg OriSVP, GENERICSFeb 15, 2022 Option Exercise$40.251,16746,97211,740Feb 17, 2022, 07:23 PM
Thoma JeanneDirectorDec 20, 2021 Buy$46.471,07249,82017,785Dec 22, 2021, 08:06 PM
Pera Antonio RDirectorDec 07, 2021 Buy$42.263,000126,79319,713Dec 09, 2021, 04:31 PM
HAUGHEY THOMASDirectorDec 06, 2021 Buy$39.382,50098,45030,202Dec 07, 2021, 04:17 PM
Lalwani NikhilPRESIDENT & CEOSep 08, 2021 Option Exercise$28.202,57772,671162,426Sep 10, 2021, 05:36 PM
Marken James G.SVP OPS & PROD DEVApr 12, 2021 Option Exercise$31.861,87859,833114,321Apr 13, 2021, 05:26 PM
Marken James G.SVP OPS & PROD DEVApr 06, 2021 Option Exercise$33.6933711,354116,199Apr 07, 2021, 08:29 PM
CAREY STEPHEN P.SENIOR VICE PRESIDENT AND CFOApr 06, 2021 Option Exercise$33.6961220,618115,542Apr 07, 2021, 08:19 PM
Marken James G.SVP OPS & PROD DEVMar 31, 2021 Option Exercise$36.1427810,047116,536Mar 31, 2021, 08:57 PM
Marken James G.SVP OPS & PROD DEVMar 29, 2021 Option Exercise$32.6852417,124116,814Mar 31, 2021, 08:57 PM
CAREY STEPHEN P.SENIOR VICE PRESIDENT AND CFOMar 31, 2021 Option Exercise$36.1450818,359116,154Mar 31, 2021, 08:56 PM
CAREY STEPHEN P.SENIOR VICE PRESIDENT AND CFOMar 29, 2021 Option Exercise$32.6895331,144116,662Mar 31, 2021, 08:56 PM
Schrepfer Robert WSVP - NEW BUS DEV & SPEC SALESMar 29, 2021 Option Exercise$32.685,566181,89787,477Mar 29, 2021, 08:11 PM
Walsh Patrick DDirectorMar 15, 2021 Buy$32.894,000131,55539,096Mar 17, 2021, 07:55 PM
Walsh Patrick DDirectorNov 09, 2020 Buy$25.965,000129,80035,096Nov 12, 2020, 05:11 PM
Walsh Patrick DCHAIRMAN, INTERIM PRES. & CEOAug 10, 2020 Buy$30.7810,000307,79030,096Aug 12, 2020, 04:18 PM
Schrepfer Robert WSVP - New Bus Dev & Spec SalesApr 07, 2020 Option Exercise$43.9339617,39653,276Apr 08, 2020, 05:55 PM
Schrepfer Robert WSVP - New Bus Dev & Spec SalesApr 06, 2020 Option Exercise$43.2266628,78553,672Apr 08, 2020, 05:55 PM
PRZYBYL ARTHURPresident and CEOApr 06, 2020 Option Exercise$43.223,282141,848192,424Apr 08, 2020, 05:54 PM
PRZYBYL ARTHURPresident and CEOApr 07, 2020 Option Exercise$43.932,11592,912190,309Apr 08, 2020, 05:54 PM
Marken James G.SVP Ops & Prod DevApr 07, 2020 Option Exercise$43.931446,32660,749Apr 08, 2020, 05:53 PM
Marken James G.SVP Ops & Prod DevApr 06, 2020 Option Exercise$43.2233714,56560,893Apr 08, 2020, 05:53 PM
CAREY STEPHEN P.Vice President and CFOApr 06, 2020 Option Exercise$43.2261226,45123,378Apr 08, 2020, 05:53 PM
Schrepfer Robert WSVP - New Bus Dev & Spec SalesMar 31, 2020 Option Exercise$40.7455222,48854,338Mar 31, 2020, 09:40 PM
Schrepfer Robert WSVP - New Bus Dev & Spec SalesMar 28, 2020 Option Exercise$37.761,03739,15754,890Mar 31, 2020, 09:40 PM
CAREY STEPHEN P.Vice President and CFOMar 31, 2020 Option Exercise$40.7450720,65523,990Mar 31, 2020, 09:39 PM
CAREY STEPHEN P.Vice President and CFOMar 28, 2020 Option Exercise$37.7695335,98524,497Mar 31, 2020, 09:39 PM
PRZYBYL ARTHURPresident and CEOMar 31, 2020 Option Exercise$40.742,679109,142195,706Mar 31, 2020, 09:37 PM
PRZYBYL ARTHURPresident and CEOMar 28, 2020 Option Exercise$37.764,204158,743198,385Mar 31, 2020, 09:37 PM
HAUGHEY THOMASDirectorMar 04, 2020 Buy$45.053,000135,15011,291Mar 05, 2020, 06:01 PM
HAUGHEY THOMASDirectorMar 03, 2020 Buy$45.182,00090,3608,291Mar 05, 2020, 06:01 PM
MERIDIAN VENTURE PARTNERS II LP10% OwnerAug 19, 2019 Sale$68.302,067141,1762,286,795Aug 23, 2019, 02:13 PM
MERIDIAN VENTURE PARTNERS II LP10% OwnerAug 20, 2019 Sale$68.185,512375,8082,281,283Aug 23, 2019, 02:13 PM
MERIDIAN VENTURE PARTNERS II LP10% OwnerAug 20, 2019 Sale$68.185,512375,8082,219,259Aug 21, 2019, 06:11 PM
MERIDIAN VENTURE PARTNERS II LP10% OwnerAug 19, 2019 Sale$68.302,067141,1762,224,771Aug 21, 2019, 06:11 PM
MERIDIAN VENTURE PARTNERS II LP10% OwnerAug 20, 2019 Sale$68.185,512375,8082,219,259Aug 21, 2019, 06:11 PM
MERIDIAN VENTURE PARTNERS II LP10% OwnerAug 19, 2019 Sale$68.302,067141,1762,224,771Aug 21, 2019, 06:11 PM
MERIDIAN VENTURE PARTNERS II LP10% OwnerAug 15, 2019 Sale$69.349,315645,9022,253,187Aug 16, 2019, 05:38 PM
MERIDIAN VENTURE PARTNERS II LP10% OwnerAug 14, 2019 Sale$69.8926,3601,842,3002,262,502Aug 16, 2019, 05:38 PM
MERIDIAN VENTURE PARTNERS II LP10% OwnerAug 16, 2019 Sale$68.0926,3491,794,1032,226,838Aug 16, 2019, 05:38 PM
MERIDIAN VENTURE PARTNERS II LP10% OwnerAug 13, 2019 Sale$71.7720,8211,494,3232,288,862Aug 13, 2019, 06:07 PM
MERIDIAN VENTURE PARTNERS II LP10% OwnerAug 12, 2019 Sale$71.4521,0161,501,5932,309,683Aug 13, 2019, 06:07 PM
MERIDIAN VENTURE PARTNERS II LP10% OwnerAug 09, 2019 Sale$71.7019,8601,423,9622,330,699Aug 13, 2019, 06:07 PM
NASH DAVIDDirectorMay 24, 2019 Buy$68.761,44599,3585,236May 29, 2019, 04:00 PM
Marken James G.SVP Ops & Prod DevMay 17, 2019 Sale$70.678,907629,45861,230May 20, 2019, 04:32 PM
Brown Robert E. JRDirectorMay 16, 2019 Option Exercise$20.432,20945,13822,561May 17, 2019, 04:30 PM
PRZYBYL ARTHURPresident and CEOMay 15, 2019 Sale$69.2514,6331,013,335202,589May 15, 2019, 05:16 PM
PRZYBYL ARTHURPresident and CEOMay 14, 2019 Sale$70.455,772406,637217,222May 15, 2019, 05:16 PM
PRZYBYL ARTHURPresident and CEOMay 13, 2019 Sale$71.109,595682,204222,994May 15, 2019, 05:16 PM
HAUGHEY THOMASDirectorMay 15, 2019 Buy$69.302,500173,2406,291May 15, 2019, 04:32 PM
Marken James G.SVP Ops & Prod DevMay 14, 2019 Sale$70.314,917345,71470,137May 15, 2019, 04:32 PM
Schrepfer Robert WSVP - New Bus Dev & Spec SalesMay 13, 2019 Sale$71.132,409171,35255,927May 13, 2019, 04:01 PM
Schrepfer Robert WSVP - New Bus Dev & Spec SalesApr 16, 2019 Option Exercise$68.6036024,69658,336Apr 18, 2019, 04:34 PM
PRZYBYL ARTHURPresident and CEOApr 16, 2019 Option Exercise$68.601,692116,071232,589Apr 18, 2019, 04:33 PM
Marken James G.SVP Ops & Prod DevApr 16, 2019 Option Exercise$68.601157,88975,054Apr 18, 2019, 04:33 PM
Marken James G.SVP Ops & Prod DevApr 07, 2019 Option Exercise$70.5014410,15275,169Apr 09, 2019, 04:45 PM
Marken James G.SVP Ops & Prod DevApr 06, 2019 Option Exercise$70.5033723,75975,313Apr 09, 2019, 04:45 PM
Schrepfer Robert WSVP - New Bus Dev & Spec SalesApr 06, 2019 Option Exercise$70.5065946,46059,088Apr 09, 2019, 04:43 PM
Schrepfer Robert WSVP - New Bus Dev & Spec SalesApr 07, 2019 Option Exercise$70.5039227,63658,696Apr 09, 2019, 04:43 PM
CAREY STEPHEN P.Vice President and CFOApr 06, 2019 Option Exercise$70.5061243,14625,450Apr 09, 2019, 04:42 PM
PRZYBYL ARTHURPresident and CEOApr 07, 2019 Option Exercise$70.502,115149,108234,281Apr 09, 2019, 04:41 PM
PRZYBYL ARTHURPresident and CEOApr 06, 2019 Option Exercise$70.503,282231,381236,396Apr 09, 2019, 04:41 PM
Schrepfer Robert WSVP - New Bus Dev & Spec SalesMar 31, 2019 Option Exercise$70.5454638,51559,747Apr 02, 2019, 04:48 PM
PRZYBYL ARTHURPresident and CEOMar 31, 2019 Option Exercise$70.542,678188,906239,678Apr 02, 2019, 04:45 PM
CAREY STEPHEN P.Vice President and CFOMar 31, 2019 Option Exercise$70.5450735,76426,062Apr 02, 2019, 04:42 PM
Marken James G.SVP Ops & Prod DevMar 31, 2019 Option Exercise$70.5427819,61075,650Apr 02, 2019, 12:00 AM
PRZYBYL ARTHURPresident and CEOMar 19, 2019 Sale$63.512,823179,289205,076Mar 20, 2019, 04:07 PM
PRZYBYL ARTHURPresident and CEOMar 18, 2019 Sale$63.5324,8021,575,671205,076Mar 20, 2019, 04:07 PM
Schrepfer Robert WSVP - New Bus Dev & Spec SalesMar 12, 2019 Option Exercise$29.657,145211,86353,484Mar 14, 2019, 06:02 AM
Schrepfer Robert WSVP - New Bus Dev & Spec SalesMar 13, 2019 Option Exercise$33.004,651153,48352,493Mar 14, 2019, 06:02 AM
Schrepfer Robert WSVP - New Bus Dev & Spec SalesMar 13, 2019 Sale$64.434,651299,64647,842Mar 14, 2019, 06:02 AM
Schrepfer Robert WSVP - New Bus Dev & Spec SalesMar 12, 2019 Sale$64.457,145460,52247,842Mar 14, 2019, 06:02 AM
Schrepfer Robert WSVP - New Bus Dev & Spec SalesSep 11, 2018 Option Exercise$6.6028,688189,34147,842Sep 14, 2018, 04:30 PM
PRZYBYL ARTHURPresident and CEOMay 22, 2018 Option Exercise$61.881,37585,085207,256May 24, 2018, 04:02 PM
Schrepfer Robert WSVP - New Bus Dev & Spec SalesMay 22, 2018 Option Exercise$61.8860037,12819,154May 24, 2018, 04:02 PM
Marken James G.SVP Ops & Prod DevMay 22, 2018 Option Exercise$61.8825315,65669,080May 24, 2018, 04:01 PM
MARSHBANKS TRACYDirectorMay 15, 2018 Sale$62.057,024435,839375,640May 16, 2018, 04:22 PM
MARSHBANKS TRACYDirectorMay 14, 2018 Sale$62.355,506343,299382,664May 16, 2018, 04:22 PM
MARSHBANKS TRACYDirectorMay 16, 2018 Sale$62.4025,7061,604,054349,934May 16, 2018, 04:22 PM
MARSHBANKS TRACYDirectorMay 10, 2018 Sale$62.0841,9142,601,871412,399May 11, 2018, 06:30 PM
MARSHBANKS TRACYDirectorMay 09, 2018 Sale$62.0520,5171,273,080430,084May 11, 2018, 06:30 PM
MARSHBANKS TRACYDirectorApr 18, 2018 Sale$62.0933,2002,061,388450,601Apr 19, 2018, 06:33 PM
Schrepfer Robert WSVP - New Bus Dev & Spec SalesApr 16, 2018 Option Exercise$60.2124714,87219,754Apr 18, 2018, 04:37 PM
PRZYBYL ARTHURPresident and CEOApr 16, 2018 Option Exercise$60.211,61196,998208,631Apr 18, 2018, 04:36 PM
Marken James G.SVP Ops & Prod DevApr 16, 2018 Option Exercise$60.211156,92469,333Apr 18, 2018, 04:34 PM
Marken James G.SVP Ops & Prod DevApr 07, 2018 Option Exercise$57.061448,21769,448Apr 10, 2018, 05:26 PM
PRZYBYL ARTHURPresident and CEOApr 07, 2018 Option Exercise$57.062,014114,919210,242Apr 10, 2018, 05:23 PM
Schrepfer Robert WSVP - New Bus Dev & Spec SalesApr 07, 2018 Option Exercise$57.0639122,31020,001Apr 10, 2018, 05:21 PM
Schrepfer Robert WSVP - New Bus Dev & Spec SalesMar 31, 2018 Option Exercise$58.2254631,78812,392Apr 03, 2018, 05:21 PM
PRZYBYL ARTHURPresident and CEOMar 31, 2018 Option Exercise$58.222,550148,461183,156Apr 03, 2018, 05:19 PM
CAREY STEPHEN P.Vice President and CFOMar 31, 2018 Option Exercise$58.2250729,5186,118Apr 03, 2018, 05:17 PM
Marken James G.SVP Ops & Prod DevMar 31, 2018 Option Exercise$58.2227816,18565,192Apr 03, 2018, 05:14 PM
RAYNOR DANIELDirectorMar 19, 2018 Sale$60.625,313322,074289,003Mar 19, 2018, 04:54 PM
RAYNOR DANIELDirectorMar 15, 2018 Sale$61.501,902116,973294,316Mar 19, 2018, 04:54 PM
MARSHBANKS TRACYDirectorMar 14, 2018 Sale$63.101,912120,647483,801Mar 16, 2018, 05:54 PM
PRZYBYL ARTHURPresident and CEOMar 12, 2018 Option Exercise$6.3615,72399,998225,706Mar 14, 2018, 07:02 PM
PRZYBYL ARTHURPresident and CEOMar 14, 2018 Sale$62.0310,000620,300185,706Mar 14, 2018, 07:02 PM
PRZYBYL ARTHURPresident and CEOMar 13, 2018 Sale$61.7630,0001,852,843202,231Mar 14, 2018, 07:02 PM
RAYNOR DANIELDirectorMar 14, 2018 Sale$62.021,919119,016296,218Mar 14, 2018, 05:33 PM
RAYNOR DANIELDirectorMar 13, 2018 Sale$61.9918,1171,123,023302,254Mar 14, 2018, 05:33 PM
RAYNOR DANIELDirectorMar 12, 2018 Sale$62.887,928498,513316,254Mar 14, 2018, 05:33 PM
MARSHBANKS TRACYDirectorMar 08, 2018 Sale$63.0815,391970,864534,543Mar 12, 2018, 07:26 PM
MARSHBANKS TRACYDirectorMar 12, 2018 Sale$63.0312,269773,315485,713Mar 12, 2018, 07:26 PM
MARSHBANKS TRACYDirectorMar 09, 2018 Sale$63.0136,5612,303,709497,982Mar 12, 2018, 07:26 PM
Marken James G.SVP Ops & Prod DevMar 05, 2018 Option Exercise$11.1118,001199,94769,647Mar 07, 2018, 05:00 PM
Marken James G.SVP Ops & Prod DevMar 05, 2018 Sale$61.924,177258,64065,470Mar 07, 2018, 05:00 PM
Schrepfer Robert WSVP - New Bus Dev & Spec SalesMar 01, 2018 Option Exercise$28.7618,750539,25041,590Mar 05, 2018, 05:01 PM
Schrepfer Robert WSVP - New Bus Dev & Spec SalesMar 01, 2018 Sale$61.6628,6521,766,77136,092Mar 05, 2018, 05:01 PM
PRZYBYL ARTHURPresident and CEOMar 01, 2018 Option Exercise$26.8223,986643,287233,969Mar 05, 2018, 05:00 PM
PRZYBYL ARTHURPresident and CEOMar 01, 2018 Sale$61.2323,9861,468,695222,643Mar 05, 2018, 05:00 PM
Schrepfer Robert WSVP - New Bus Dev & Spec SalesMay 22, 2017 Option Exercise$47.0145021,15422,840May 24, 2017, 04:31 PM
Marken James G.SVP Ops & Prod DevMay 22, 2017 Option Exercise$47.0127813,06951,549May 24, 2017, 04:30 PM
PRZYBYL ARTHURPresident and CEOMay 22, 2017 Option Exercise$47.0199146,587210,833May 24, 2017, 04:30 PM
PRZYBYL ARTHURPresident and CEOApr 17, 2017 Option Exercise$51.221,16159,466211,824Apr 18, 2017, 04:33 PM
Schrepfer Robert WSVP - New Bus Dev & Spec SalesApr 17, 2017 Option Exercise$51.2227013,82923,290Apr 18, 2017, 04:30 PM
PRZYBYL ARTHURPresident and CEOApr 07, 2017 Option Exercise$51.241,45174,349212,985Apr 11, 2017, 04:34 PM
Schrepfer Robert WSVP - New Bus Dev & Spec SalesApr 07, 2017 Option Exercise$51.2442721,87923,560Apr 11, 2017, 04:31 PM
Brown Robert E. JRDirectorNov 15, 2016 Option Exercise$17.755,45896,86415,568Nov 16, 2016, 04:21 PM
PRZYBYL ARTHURPresident and CEOAug 22, 2016 Option Exercise$12.7553,178677,872229,261Aug 23, 2016, 04:14 PM
PRZYBYL ARTHURPresident and CEOAug 22, 2016 Sale$66.9737,4552,508,361191,806Aug 23, 2016, 04:14 PM
Schrepfer Robert WVP Bus Dev & Con MfgAug 08, 2016 Sale$67.0612,500838,20917,362Aug 09, 2016, 04:30 PM
PRZYBYL ARTHURPresident and CEOMay 22, 2016 Option Exercise$49.5499149,094176,919May 24, 2016, 04:53 PM
Schrepfer Robert WVP Bus Dev & Con MfgMay 22, 2016 Option Exercise$49.5445022,29329,862May 24, 2016, 04:52 PM
PRZYBYL ARTHURPresident and CEOApr 16, 2016 Option Exercise$43.251,16150,213177,910Apr 18, 2016, 06:25 PM
Schrepfer Robert WVP Bus Dev & Con MfgFeb 18, 2016 Option Exercise$6.606,00039,60025,562Feb 19, 2016, 04:16 PM
PRZYBYL ARTHURPresident and CEOJan 08, 2016 Option Exercise$6.3616,446104,597160,321Jan 11, 2016, 04:50 PM
Marken James G.Vice President, OperationsDec 18, 2015 Sale$43.263,500151,41045,983Dec 22, 2015, 04:23 PM
PRZYBYL ARTHURPresident and CEONov 12, 2015 Buy$40.952,500102,375145,195Nov 12, 2015, 04:44 PM
Arnold Charlotte C.Vice President and CFOSep 25, 2015 Option Exercise$7.6119,060145,03850,098Sep 28, 2015, 05:20 PM
Arnold Charlotte C.Vice President and CFOSep 02, 2015 Option Exercise$33.002,10669,49831,038Sep 03, 2015, 04:30 PM
PRZYBYL ARTHURPresident and CEOAug 10, 2015 Option Exercise$6.3610,00063,600142,695Aug 10, 2015, 06:29 PM
Marken James G.Vice President, OperationsJul 17, 2015 Option Exercise$6.367,39547,03249,483Jul 20, 2015, 04:30 PM
Schrepfer Robert WVP Bus Dev & Con MfgJun 18, 2015 Option Exercise$6.609,06259,80919,562Jun 19, 2015, 04:30 PM
Arnold Charlotte C.VP and CFOMay 22, 2015 Option Exercise$53.1065334,67428,932May 27, 2015, 04:31 PM
PRZYBYL ARTHURPresident and CEOMay 22, 2015 Option Exercise$53.101,46978,004132,695May 27, 2015, 04:30 PM
Marken James G.Vice President, OperationsMay 13, 2015 Option Exercise$11.169,020100,65742,088May 14, 2015, 04:30 PM
PRZYBYL ARTHURPresident and CEOMay 07, 2015 Option Exercise$6.365,00031,800134,164May 08, 2015, 09:00 AM
Arnold Charlotte C.VP and CFOMay 06, 2015 Option Exercise$6.364,00025,44029,585May 07, 2015, 05:05 PM
Schrepfer Robert WVP Bus Dev & Con MfgMay 06, 2015 Option Exercise$6.602,50016,50010,500May 07, 2015, 05:03 PM
Marken James G.Vice President, OperationsMar 19, 2015 Sale$66.5015,000997,50031,568Mar 19, 2015, 04:55 PM
MARSHBANKS TRACYDirectorMar 12, 2015 Sale$63.005,978376,61415,656Mar 16, 2015, 09:30 PM
MARSHBANKS TRACYDirectorMar 12, 2015 Sale$63.00143,5169,041,508375,829Mar 16, 2015, 09:30 PM
MARSHBANKS TRACYDirectorMar 12, 2015 Sale$63.002,241141,1835,870Mar 16, 2015, 09:30 PM
MARSHBANKS TRACYDirectorMar 12, 2015 Sale$63.0058,2653,670,695152,579Mar 16, 2015, 09:30 PM
Arnold Charlotte C.Vice President and CFOMar 12, 2015 Sale$63.0045,0002,835,00021,385Mar 16, 2015, 05:45 PM
PRZYBYL ARTHURPresident and CEOMar 12, 2015 Sale$63.0075,0004,725,000114,164Mar 16, 2015, 05:43 PM
MERIDIAN VENTURE PARTNERS II LP10% OwnerMar 12, 2015 Sale$63.00300,00018,900,0002,350,559Mar 16, 2015, 05:36 PM
RAYNOR DANIELDirectorMar 12, 2015 Sale$63.00200,00012,600,000324,182Mar 16, 2015, 05:32 PM
MANGANO ROSS JDirectorSep 15, 2014 Buy$27.493,00082,47726,914Sep 16, 2014, 04:40 PM
PRZYBYL ARTHURPresident and CEOSep 09, 2014 Buy$26.501,00026,500189,162Sep 09, 2014, 05:56 PM
Marken James G.Vice President, OperationsJun 18, 2014 Sale$34.285,000171,40046,568Jun 19, 2014, 07:50 AM
MARSHBANKS TRACYDirectorMay 08, 2014 Sale$30.021,38141,45521,634May 12, 2014, 10:48 AM
MANGANO ROSS JDirectorMay 07, 2014 Buy$30.382,00060,76023,914May 07, 2014, 01:48 PM
MARSHBANKS TRACYDirectorMar 21, 2014 Sale$31.06621,9268,111Mar 21, 2014, 02:43 PM
MARSHBANKS TRACYDirectorMar 21, 2014 Sale$31.061,60449,821210,844Mar 21, 2014, 02:43 PM
MARSHBANKS TRACYDirectorMar 21, 2014 Sale$31.063,951122,720519,345Mar 21, 2014, 02:43 PM
MARSHBANKS TRACYDirectorMar 20, 2014 Sale$31.541775,5838,173Mar 21, 2014, 02:43 PM
MARSHBANKS TRACYDirectorMar 20, 2014 Sale$31.544,612145,466212,448Mar 21, 2014, 02:43 PM
MARSHBANKS TRACYDirectorMar 20, 2014 Sale$31.5411,361358,335523,296Mar 21, 2014, 02:43 PM
MERIDIAN VENTURE PARTNERS II LP10% OwnerMar 19, 2014 Sale$32.4510,922354,3902,661,310Mar 20, 2014, 08:44 PM
MERIDIAN VENTURE PARTNERS II LP10% OwnerMar 20, 2014 Sale$31.7610,000317,6002,650,559Mar 20, 2014, 08:44 PM
MARSHBANKS TRACYDirectorMar 18, 2014 Sale$33.8314,851502,356537,643Mar 19, 2014, 05:13 PM
MARSHBANKS TRACYDirectorMar 19, 2014 Sale$32.98471,5508,350Mar 19, 2014, 05:13 PM
MARSHBANKS TRACYDirectorMar 19, 2014 Sale$32.981,21340,002217,060Mar 19, 2014, 05:13 PM
MARSHBANKS TRACYDirectorMar 19, 2014 Sale$32.982,98698,473534,657Mar 19, 2014, 05:13 PM
MARSHBANKS TRACYDirectorMar 18, 2014 Sale$33.832327,8488,397Mar 19, 2014, 05:13 PM
MARSHBANKS TRACYDirectorMar 18, 2014 Sale$33.836,029203,939218,273Mar 19, 2014, 05:13 PM
MERIDIAN VENTURE PARTNERS II LP10% OwnerMar 13, 2014 Sale$31.6852,4041,660,3682,750,911Mar 18, 2014, 08:51 PM
MERIDIAN VENTURE PARTNERS II LP10% OwnerMar 12, 2014 Sale$33.6635,3191,188,8842,786,942Mar 18, 2014, 08:51 PM
MERIDIAN VENTURE PARTNERS II LP10% OwnerMar 18, 2014 Sale$33.8320,542694,9362,671,481Mar 18, 2014, 08:49 PM
MERIDIAN VENTURE PARTNERS II LP10% OwnerMar 17, 2014 Sale$34.7510,339359,2802,692,023Mar 18, 2014, 08:49 PM
MERIDIAN VENTURE PARTNERS II LP10% OwnerMar 14, 2014 Sale$33.9929,6591,008,0912,707,114Mar 18, 2014, 08:49 PM
RAYNOR DANIELDirectorMar 14, 2014 Sale$33.8512,347417,946524,182Mar 18, 2014, 08:46 PM
RAYNOR DANIELDirectorMar 12, 2014 Sale$33.8921,111715,556538,427Mar 18, 2014, 08:44 PM
RAYNOR DANIELDirectorMar 12, 2014 Sale$33.8921,111715,4523,324,738Mar 14, 2014, 07:23 PM
MERIDIAN VENTURE PARTNERS II LP10% OwnerMar 13, 2014 Sale$31.6952,4041,660,68316,830,746Mar 14, 2014, 07:20 PM
MERIDIAN VENTURE PARTNERS II LP10% OwnerMar 12, 2014 Sale$33.6635,3191,188,83816,883,150Mar 14, 2014, 07:20 PM
Arnold Charlotte C.Chief Financial OfficerMar 06, 2014 Option Exercise$36.642,00073,28760,404Mar 07, 2014, 05:10 PM
Arnold Charlotte C.Chief Financial OfficerMar 05, 2014 Option Exercise$36.431,35749,43662,404Mar 07, 2014, 05:10 PM
PRZYBYL ARTHURPresident and CEOMar 05, 2014 Option Exercise$36.575,641206,298175,368Mar 07, 2014, 05:09 PM
Arnold Charlotte C.Chief Financial OfficerFeb 25, 2014 Option Exercise$32.771,36444,69360,086Feb 27, 2014, 03:33 PM
PRZYBYL ARTHURPresident and CEOFeb 25, 2014 Option Exercise$32.865,644185,475168,870Feb 27, 2014, 03:30 PM
PRZYBYL ARTHURPresident and CEOFeb 12, 2014 Option Exercise$21.005,644118,521162,375Feb 14, 2014, 04:52 PM
Arnold Charlotte C.Chief Financial OfficerFeb 12, 2014 Option Exercise$21.001,36428,64157,775Feb 14, 2014, 04:49 PM
PRZYBYL ARTHURPresident and CEOFeb 05, 2014 Option Exercise$19.795,644111,701155,880Feb 07, 2014, 05:52 PM
Arnold Charlotte C.Chief Financial OfficerFeb 05, 2014 Option Exercise$19.831,36427,04355,464Feb 07, 2014, 05:50 PM
PRZYBYL ARTHURPresident and CEOJan 29, 2014 Option Exercise$21.345,644120,438149,385Jan 31, 2014, 01:09 PM
Arnold Charlotte C.Chief Financial OfficerJan 29, 2014 Option Exercise$21.321,36429,08353,153Jan 31, 2014, 01:03 PM
Arnold Charlotte C.Chief Financial OfficerJan 22, 2014 Option Exercise$23.971,36432,69350,842Jan 24, 2014, 05:18 PM
PRZYBYL ARTHURPresident and CEOJan 22, 2014 Option Exercise$23.995,644135,396142,890Jan 24, 2014, 05:11 PM
PRZYBYL ARTHURPresident and CEOJan 15, 2014 Option Exercise$23.115,644130,413136,395Jan 17, 2014, 04:06 PM
Arnold Charlotte C.Chief Financial OfficerJan 15, 2014 Option Exercise$23.091,36431,48948,531Jan 17, 2014, 04:05 PM
Arnold Charlotte C.Chief Financial OfficerJan 08, 2014 Option Exercise$20.801,36428,36746,220Jan 10, 2014, 11:52 AM
PRZYBYL ARTHURPresident and CEOJan 08, 2014 Option Exercise$20.835,644117,536129,900Jan 10, 2014, 11:50 AM
Arnold Charlotte C.Chief Financial OfficerJan 02, 2014 Option Exercise$19.411,36426,47843,909Jan 06, 2014, 03:08 PM
PRZYBYL ARTHURPresident and CEOJan 02, 2014 Option Exercise$19.415,644109,561123,405Jan 06, 2014, 03:07 PM
PRZYBYL ARTHURPresident and CEODec 26, 2013 Option Exercise$16.915,64495,439116,910Dec 27, 2013, 11:53 AM
Arnold Charlotte C.Chief Financial OfficerDec 26, 2013 Option Exercise$16.891,36423,04141,598Dec 27, 2013, 11:50 AM
Arnold Charlotte C.Chief Financial OfficerDec 18, 2013 Option Exercise$15.091,36420,58239,287Dec 20, 2013, 11:46 AM
PRZYBYL ARTHURPresident and CEODec 18, 2013 Option Exercise$15.135,64485,385110,415Dec 20, 2013, 11:44 AM
Arnold Charlotte C.Chief Financial OfficerDec 11, 2013 Option Exercise$14.731,36420,09036,976Dec 13, 2013, 04:52 PM
PRZYBYL ARTHURPresident and CEODec 11, 2013 Option Exercise$14.725,64483,075103,920Dec 13, 2013, 04:49 PM
PRZYBYL ARTHURPresident and CEODec 04, 2013 Option Exercise$13.015,64473,44497,425Dec 06, 2013, 04:10 PM
Arnold Charlotte C.Chief Financial OfficerDec 04, 2013 Option Exercise$13.021,36417,75434,665Dec 06, 2013, 03:58 PM
PRZYBYL ARTHURPresident and CEONov 27, 2013 Option Exercise$14.595,64482,35790,930Nov 27, 2013, 08:34 PM
Arnold Charlotte C.Chief Financial OfficerNov 27, 2013 Option Exercise$14.601,36419,92032,354Nov 27, 2013, 08:33 PM
PRZYBYL ARTHURPresident and CEONov 22, 2013 Option Exercise$13.425,64475,71784,435Nov 22, 2013, 07:52 PM
Arnold Charlotte C.Chief Financial OfficerNov 22, 2013 Option Exercise$13.431,36418,32030,043Nov 22, 2013, 07:51 PM
PRZYBYL ARTHURPresident and CEONov 13, 2013 Option Exercise$11.325,64463,88777,940Nov 15, 2013, 04:21 PM
Arnold Charlotte C.Chief Financial OfficerNov 13, 2013 Option Exercise$11.321,36415,44127,732Nov 15, 2013, 04:21 PM
MANGANO ROSS JDirectorNov 07, 2013 Buy$11.279,000101,43021,914Nov 12, 2013, 02:29 PM
Arnold Charlotte C.Chief Financial OfficerNov 06, 2013 Option Exercise$11.091,36415,13025,421Nov 08, 2013, 05:26 PM
PRZYBYL ARTHURPresident and CEONov 06, 2013 Option Exercise$11.105,64462,67371,445Nov 08, 2013, 05:23 PM
PRZYBYL ARTHURPresident and CEOOct 30, 2013 Option Exercise$10.085,64456,87364,950Nov 01, 2013, 04:48 PM
Arnold Charlotte C.Chief Financial OfficerOct 30, 2013 Option Exercise$10.071,36413,73523,110Nov 01, 2013, 04:46 PM
Arnold Charlotte C.Chief Financial OfficerOct 23, 2013 Option Exercise$10.091,36413,76820,799Oct 25, 2013, 07:31 PM
PRZYBYL ARTHURPresident and CEOOct 23, 2013 Option Exercise$11.455,64464,64058,455Oct 25, 2013, 07:28 PM
Arnold Charlotte C.Chief Financial OfficerOct 16, 2013 Option Exercise$10.671,36414,55718,488Oct 18, 2013, 05:05 PM
PRZYBYL ARTHURPresident and CEOOct 16, 2013 Option Exercise$10.665,64460,16851,960Oct 18, 2013, 05:04 PM
PRZYBYL ARTHURPresident and CEOOct 09, 2013 Option Exercise$9.955,64456,16145,465Oct 11, 2013, 12:32 PM
Arnold Charlotte C.Chief Financial OfficerOct 09, 2013 Option Exercise$9.931,36413,55016,177Oct 11, 2013, 12:32 PM
PRZYBYL ARTHURPresident and CEOOct 02, 2013 Option Exercise$10.105,64456,98438,970Oct 04, 2013, 04:18 PM
Arnold Charlotte C.Chief Financial OfficerOct 02, 2013 Option Exercise$10.091,36413,76813,866Oct 04, 2013, 04:17 PM
Arnold Charlotte C.Chief Financial OfficerSep 25, 2013 Option Exercise$9.111,36412,42111,555Sep 27, 2013, 05:13 PM
PRZYBYL ARTHURPresident and CEOSep 25, 2013 Option Exercise$9.095,64451,28432,475Sep 27, 2013, 05:12 PM
PRZYBYL ARTHURPresident and CEOSep 18, 2013 Option Exercise$8.195,64446,21625,980Sep 20, 2013, 07:03 PM
Arnold Charlotte C.Chief Financial OfficerSep 18, 2013 Option Exercise$8.181,36411,1609,244Sep 20, 2013, 07:01 PM
Arnold Charlotte C.Chief Financial OfficerSep 11, 2013 Option Exercise$6.971,3649,5016,933Sep 13, 2013, 05:33 PM
PRZYBYL ARTHURPresident and CEOSep 11, 2013 Option Exercise$6.975,64439,31719,485Sep 13, 2013, 05:27 PM
PRZYBYL ARTHURPresident and CEOSep 04, 2013 Option Exercise$6.955,64439,23412,990Sep 05, 2013, 05:41 PM
Arnold Charlotte C.Chief Financial OfficerSep 04, 2013 Option Exercise$6.961,3649,4884,622Sep 05, 2013, 05:38 PM
PRZYBYL ARTHURPresident and CEOAug 28, 2013 Option Exercise$7.075,64439,8756,495Aug 30, 2013, 06:27 PM
Arnold Charlotte C.Chief Financial OfficerAug 28, 2013 Option Exercise$7.081,3649,6622,311Aug 30, 2013, 06:24 PM
MANGANO ROSS JDirectorAug 20, 2013 Buy$7.4710,00074,65918,550Aug 22, 2013, 06:01 PM
ROSENOW EDWARD C IIIDirectorNov 14, 2011 Buy$2.373,0007,11020,540Nov 15, 2011, 11:15 AM
SULLIVAN LOUIS WDirectorAug 15, 2011 Buy$2.6710,00026,70047,898Aug 29, 2011, 12:40 PM
MANGANO ROSS JDirectorAug 12, 2011 Buy$2.4025,00060,00073,333Aug 12, 2011, 12:10 PM
DONENBERG PHILIP BSr. VP of Finance, CFO & SecyAug 08, 2011 Buy$2.231,0002,23044,322Aug 09, 2011, 10:51 AM
DONENBERG PHILIP BSr. VP of Finance, CFO & SecyAug 05, 2011 Buy$2.191,0002,19043,322Aug 08, 2011, 11:54 AM
MANGANO ROSS JDirectorAug 05, 2011 Buy$2.2180,000176,800165,756Aug 05, 2011, 12:59 PM
DONENBERG PHILIP BSr. VP of Finance, CFO & Sec'yJan 21, 2011 Buy$1.881,0001,88042,322Jan 21, 2011, 12:21 PM
DONENBERG PHILIP BSr. VP of Finance, CFO & Sec'yJan 19, 2011 Buy$1.881,0001,88041,322Jan 20, 2011, 09:28 AM
SIMES STEPHEN MVice Chairman, President & CEOJan 18, 2011 Buy$1.775,0008,849202,167Jan 19, 2011, 09:45 AM
SULLIVAN LOUIS WDirectorJan 13, 2011 Buy$1.7210,00017,20037,898Jan 14, 2011, 10:20 AM
MANGANO ROSS JDirectorDec 07, 2010 Buy$1.4720,00029,4001,929,661Dec 08, 2010, 09:46 AM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPS04/16/2024386,211
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPS04/15/2024491,771
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPS04/17/2024622,608
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.04/12/202416,948
Marken James G.SVP OPS & PROD DEV04/10/2024187,421
CAREY STEPHEN P.SVP & CFO04/10/2024303,597
Gassert ChadSVP - CORP. DEV. & STRATEGY04/01/20241,345,000
CAREY STEPHEN P.SVP & CFO03/23/2024432,092
Marken James G.SVP OPS & PROD DEV03/23/2024254,176
Lalwani NikhilPRESIDENT & CEO03/23/20241,214,519
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.03/13/202416,635
Gassert ChadSVP - CORP. DEV. & STRATEGY03/11/20241,316,200
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPS03/08/2024671,700
CAREY STEPHEN P.SVP & CFO03/07/2024281,249
CAREY STEPHEN P.SVP & CFO03/11/2024510,438
Lalwani NikhilPRESIDENT & CEO03/07/20241,138,073
Lalwani NikhilPRESIDENT & CEO03/08/20241,093,682
Lalwani NikhilPRESIDENT & CEO03/06/20241,897,787
Marken James G.SVP OPS & PROD DEV03/07/2024135,688
Marken James G.SVP OPS & PROD DEV03/07/20241,615,313
Gutwerg OriSVP, GENERICS03/07/2024166,375
Mutz ChristopherHEAD OF RARE DISEASE03/07/2024140,758
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPS03/07/20241,000,890
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPS03/06/2024970,396
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPS03/05/2024659,578
Mutz ChristopherHEAD OF RARE DISEASE03/05/2024330,000
Pera Antonio RDirector03/04/2024456,400
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPS02/29/202475,926
Mutz ChristopherHEAD OF RARE DISEASE02/29/202486,279
Marken James G.SVP OPS & PROD DEV02/29/202471,595
Lalwani NikhilPRESIDENT & CEO02/29/2024677,647
Gutwerg OriSVP, GENERICS02/29/2024106,242
Gassert ChadSVP - CORP. DEV. & STRATEGY02/29/2024110,640
Davis KristaSVP, CHIEF HR OFFICER02/29/202479,377
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.02/29/202479,377
CAREY STEPHEN P.SVP & CFO02/29/2024129,520
Gutwerg OriSVP, GENERICS02/15/202471,592
Mutz ChristopherHEAD OF RARE DISEASE02/15/202472,571
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.02/13/202414,010
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPS01/23/2024846,600
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPS01/22/2024318,467
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPS01/19/2024251,399
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPS01/18/2024541,055
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPS01/17/2024551,100
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPS01/16/2024278,150
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.01/12/202414,108
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPS12/19/20231,316,250
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPS12/18/2023683,083
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPS12/15/2023627,917
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.12/11/202312,302
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPS11/17/2023663,000
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPS11/15/2023410,185
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPS11/14/20231,217,859
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPS11/16/2023333,104
Davis KristaSVP, CHIEF HR OFFICER11/15/2023141,090
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPS11/16/2023333,104
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPS11/15/2023410,185
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPS11/14/20231,174,791
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.11/13/202313,007
Mutz ChristopherHEAD OF RARE DISEASE11/10/2023157,410
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPS10/19/2023570,600
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPS10/18/2023360,663
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPS10/17/2023512,606
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPS10/16/2023761,704
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPS10/13/2023687,332
Gassert ChadSVP - CORP. DEV. & STRATEGY10/02/20231,129,600
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPS09/19/20231,551,140
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPS09/18/2023519,317
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPS09/15/20231,020,160
Davis KristaSVP, CHIEF HR OFFICER09/12/202391,998
Lalwani NikhilPRESIDENT & CEO09/08/2023225,833
Gassert ChadSVP - CORP. DEV. & STRATEGY09/01/20231,294,000
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPS08/29/20231,584,250
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPS08/28/20231,576,500
Gutwerg OriSVP, GENERICS08/23/2023425,178
Gutwerg OriSVP, GENERICS08/23/2023970,851
Marken James G.SVP OPS & PROD DEV08/23/2023207,224
Marken James G.SVP OPS & PROD DEV08/23/2023247,716
MERIDIAN VENTURE PARTNERS II LP10% Owner08/16/202311,700,000
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPS08/15/20231,361,976
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPS08/14/20231,705,474
CAREY STEPHEN P.SVP & CFO08/14/20231,082,505
Pera Antonio RDirector08/14/2023181,110
Lalwani NikhilPRESIDENT & CEO08/15/2023336,864
Lalwani NikhilPRESIDENT & CEO08/11/20233,272,462
Lalwani NikhilPRESIDENT & CEO08/15/2023710,086
Gassert ChadSVP - CORP. DEV. & STRATEGY08/01/20231,021,200
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPS07/21/2023604,440
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPS07/20/2023309,120
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPS07/19/2023307,284
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.07/18/202390,444
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPS07/18/2023347,328
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPS07/17/2023501,971
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPS07/14/2023504,300
Gassert ChadSVP - CORP. DEV. & STRATEGY07/03/20231,068,600
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPS06/21/2023615,244
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPS06/20/2023761,138
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPS06/23/2023514,900
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPS06/22/2023693,630
Gassert ChadSVP - CORP. DEV. & STRATEGY06/22/20231,026,400
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPS06/22/2023693,630
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPS06/21/2023615,244
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPS06/20/2023761,138
CAREY STEPHEN P.SVP & CFO04/10/2023174,559
Marken James G.SVP OPS & PROD DEV04/10/202388,127
Marken James G.SVP OPS & PROD DEV03/28/202320,237
CAREY STEPHEN P.SVP AND CFO03/28/202354,840
Marken James G.SVP OPS & PROD DEV03/23/202392,735
Lalwani NikhilPRESIDENT & CEO03/23/2023660,148
CAREY STEPHEN P.SVP AND CFO03/23/2023159,752
Mutz ChristopherHEAD OF RARE DISEASE03/07/202384,125
Gutwerg OriSVP, GENERICS03/07/2023103,587
CAREY STEPHEN P.SVP AND CFO03/07/2023154,938
Lalwani NikhilPRESIDENT & CEO03/07/2023604,270
Marken James G.SVP OPS & PROD DEV03/07/2023108,806
Mutz ChristopherHEAD OF RARE DISEASE02/15/202358,192
Gutwerg OriSVP, GENERICS02/15/202357,426
MERIDIAN VENTURE PARTNERS II LP10% Owner12/01/20227,700,000
Lalwani NikhilPRESIDENT & CEO09/08/2022137,126
Marken James G.SVP OPS & PROD DEV08/15/2022195,464
Marken James G.SVP OPS & PROD DEV08/12/2022477,605
Marken James G.SVP OPS & PROD DEV04/10/202256,171
CAREY STEPHEN P.SENIOR VICE PRESIDENT AND CFO04/10/2022135,612
CAREY STEPHEN P.SENIOR VICE PRESIDENT AND CFO04/06/202227,077
Marken James G.SVP OPS & PROD DEV04/06/202210,006
Marken James G.SVP OPS & PROD DEV03/28/202214,761
CAREY STEPHEN P.SENIOR VICE PRESIDENT AND CFO03/28/202240,001
Marken James G.SVP OPS & PROD DEV03/23/202266,278
CAREY STEPHEN P.SENIOR VICE PRESIDENT AND CFO03/23/2022112,634
Lalwani NikhilPRESIDENT & CEO03/23/2022471,782
Lalwani NikhilPRESIDENT & CEO03/21/2022199,997
Walsh Patrick DDirector03/21/2022138,794
Gassert ChadSVP - CORP. DEV. & STRATEGY03/21/2022139,342
Gassert ChadSVP - CORP. DEV. & STRATEGY03/18/2022135,744
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPS03/17/2022138,251
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPS03/17/2022138,251
Mutz ChristopherHEAD OF RARE DISEASE02/15/202247,656
Gutwerg OriSVP, GENERICS02/15/202246,972
Thoma JeanneDirector12/20/202149,820
Pera Antonio RDirector12/07/2021126,793
HAUGHEY THOMASDirector12/06/202198,450
Lalwani NikhilPRESIDENT & CEO09/08/202172,671
Marken James G.SVP OPS & PROD DEV04/12/202159,833
Marken James G.SVP OPS & PROD DEV04/06/202111,354
CAREY STEPHEN P.SENIOR VICE PRESIDENT AND CFO04/06/202120,618
Marken James G.SVP OPS & PROD DEV03/31/202110,047
Marken James G.SVP OPS & PROD DEV03/29/202117,124
CAREY STEPHEN P.SENIOR VICE PRESIDENT AND CFO03/31/202118,359
CAREY STEPHEN P.SENIOR VICE PRESIDENT AND CFO03/29/202131,144
Schrepfer Robert WSVP - NEW BUS DEV & SPEC SALES03/29/2021181,897
Walsh Patrick DDirector03/15/2021131,555
Walsh Patrick DDirector11/09/2020129,800
Walsh Patrick DCHAIRMAN, INTERIM PRES. & CEO08/10/2020307,790
Schrepfer Robert WSVP - New Bus Dev & Spec Sales04/07/202017,396
Schrepfer Robert WSVP - New Bus Dev & Spec Sales04/06/202028,785
PRZYBYL ARTHURPresident and CEO04/06/2020141,848
PRZYBYL ARTHURPresident and CEO04/07/202092,912
Marken James G.SVP Ops & Prod Dev04/07/20206,326
Marken James G.SVP Ops & Prod Dev04/06/202014,565
CAREY STEPHEN P.Vice President and CFO04/06/202026,451
Schrepfer Robert WSVP - New Bus Dev & Spec Sales03/31/202022,488
Schrepfer Robert WSVP - New Bus Dev & Spec Sales03/28/202039,157
CAREY STEPHEN P.Vice President and CFO03/31/202020,655
CAREY STEPHEN P.Vice President and CFO03/28/202035,985
PRZYBYL ARTHURPresident and CEO03/31/2020109,142
PRZYBYL ARTHURPresident and CEO03/28/2020158,743
HAUGHEY THOMASDirector03/04/2020135,150
HAUGHEY THOMASDirector03/03/202090,360
MERIDIAN VENTURE PARTNERS II LP10% Owner08/19/2019141,176
MERIDIAN VENTURE PARTNERS II LP10% Owner08/20/2019375,808
MERIDIAN VENTURE PARTNERS II LP10% Owner08/20/2019375,808
MERIDIAN VENTURE PARTNERS II LP10% Owner08/19/2019141,176
MERIDIAN VENTURE PARTNERS II LP10% Owner08/20/2019375,808
MERIDIAN VENTURE PARTNERS II LP10% Owner08/19/2019141,176
MERIDIAN VENTURE PARTNERS II LP10% Owner08/15/2019645,902
MERIDIAN VENTURE PARTNERS II LP10% Owner08/14/20191,842,300
MERIDIAN VENTURE PARTNERS II LP10% Owner08/16/20191,794,103
MERIDIAN VENTURE PARTNERS II LP10% Owner08/13/20191,494,323
MERIDIAN VENTURE PARTNERS II LP10% Owner08/12/20191,501,593
MERIDIAN VENTURE PARTNERS II LP10% Owner08/09/20191,423,962
NASH DAVIDDirector05/24/201999,358
Marken James G.SVP Ops & Prod Dev05/17/2019629,458
Brown Robert E. JRDirector05/16/201945,138
PRZYBYL ARTHURPresident and CEO05/15/20191,013,335
PRZYBYL ARTHURPresident and CEO05/14/2019406,637
PRZYBYL ARTHURPresident and CEO05/13/2019682,204
HAUGHEY THOMASDirector05/15/2019173,240
Marken James G.SVP Ops & Prod Dev05/14/2019345,714
Schrepfer Robert WSVP - New Bus Dev & Spec Sales05/13/2019171,352
Schrepfer Robert WSVP - New Bus Dev & Spec Sales04/16/201924,696
PRZYBYL ARTHURPresident and CEO04/16/2019116,071
Marken James G.SVP Ops & Prod Dev04/16/20197,889
Marken James G.SVP Ops & Prod Dev04/07/201910,152
Marken James G.SVP Ops & Prod Dev04/06/201923,759
Schrepfer Robert WSVP - New Bus Dev & Spec Sales04/06/201946,460
Schrepfer Robert WSVP - New Bus Dev & Spec Sales04/07/201927,636
CAREY STEPHEN P.Vice President and CFO04/06/201943,146
PRZYBYL ARTHURPresident and CEO04/07/2019149,108
PRZYBYL ARTHURPresident and CEO04/06/2019231,381
Schrepfer Robert WSVP - New Bus Dev & Spec Sales03/31/201938,515
PRZYBYL ARTHURPresident and CEO03/31/2019188,906
CAREY STEPHEN P.Vice President and CFO03/31/201935,764
Marken James G.SVP Ops & Prod Dev03/31/201919,610
PRZYBYL ARTHURPresident and CEO03/19/2019179,289
PRZYBYL ARTHURPresident and CEO03/18/20191,575,671
Schrepfer Robert WSVP - New Bus Dev & Spec Sales03/12/2019211,863
Schrepfer Robert WSVP - New Bus Dev & Spec Sales03/13/2019153,483
Schrepfer Robert WSVP - New Bus Dev & Spec Sales03/13/2019299,646
Schrepfer Robert WSVP - New Bus Dev & Spec Sales03/12/2019460,522
Schrepfer Robert WSVP - New Bus Dev & Spec Sales09/11/2018189,341
PRZYBYL ARTHURPresident and CEO05/22/201885,085
Schrepfer Robert WSVP - New Bus Dev & Spec Sales05/22/201837,128
Marken James G.SVP Ops & Prod Dev05/22/201815,656
MARSHBANKS TRACYDirector05/15/2018435,839
MARSHBANKS TRACYDirector05/14/2018343,299
MARSHBANKS TRACYDirector05/16/20181,604,054
MARSHBANKS TRACYDirector05/10/20182,601,871
MARSHBANKS TRACYDirector05/09/20181,273,080
MARSHBANKS TRACYDirector04/18/20182,061,388
Schrepfer Robert WSVP - New Bus Dev & Spec Sales04/16/201814,872
PRZYBYL ARTHURPresident and CEO04/16/201896,998
Marken James G.SVP Ops & Prod Dev04/16/20186,924
Marken James G.SVP Ops & Prod Dev04/07/20188,217
PRZYBYL ARTHURPresident and CEO04/07/2018114,919
Schrepfer Robert WSVP - New Bus Dev & Spec Sales04/07/201822,310
Schrepfer Robert WSVP - New Bus Dev & Spec Sales03/31/201831,788
PRZYBYL ARTHURPresident and CEO03/31/2018148,461
CAREY STEPHEN P.Vice President and CFO03/31/201829,518
Marken James G.SVP Ops & Prod Dev03/31/201816,185
RAYNOR DANIELDirector03/19/2018322,074
RAYNOR DANIELDirector03/15/2018116,973
MARSHBANKS TRACYDirector03/14/2018120,647
PRZYBYL ARTHURPresident and CEO03/12/201899,998
PRZYBYL ARTHURPresident and CEO03/14/2018620,300
PRZYBYL ARTHURPresident and CEO03/13/20181,852,843
RAYNOR DANIELDirector03/14/2018119,016
RAYNOR DANIELDirector03/13/20181,123,023
RAYNOR DANIELDirector03/12/2018498,513
MARSHBANKS TRACYDirector03/08/2018970,864
MARSHBANKS TRACYDirector03/12/2018773,315
MARSHBANKS TRACYDirector03/09/20182,303,709
Marken James G.SVP Ops & Prod Dev03/05/2018199,947
Marken James G.SVP Ops & Prod Dev03/05/2018258,640
Schrepfer Robert WSVP - New Bus Dev & Spec Sales03/01/2018539,250
Schrepfer Robert WSVP - New Bus Dev & Spec Sales03/01/20181,766,771
PRZYBYL ARTHURPresident and CEO03/01/2018643,287
PRZYBYL ARTHURPresident and CEO03/01/20181,468,695
Schrepfer Robert WSVP - New Bus Dev & Spec Sales05/22/201721,154
Marken James G.SVP Ops & Prod Dev05/22/201713,069
PRZYBYL ARTHURPresident and CEO05/22/201746,587
PRZYBYL ARTHURPresident and CEO04/17/201759,466
Schrepfer Robert WSVP - New Bus Dev & Spec Sales04/17/201713,829
PRZYBYL ARTHURPresident and CEO04/07/201774,349
Schrepfer Robert WSVP - New Bus Dev & Spec Sales04/07/201721,879
Brown Robert E. JRDirector11/15/201696,864
PRZYBYL ARTHURPresident and CEO08/22/2016677,872
PRZYBYL ARTHURPresident and CEO08/22/20162,508,361
Schrepfer Robert WVP Bus Dev & Con Mfg08/08/2016838,209
PRZYBYL ARTHURPresident and CEO05/22/201649,094
Schrepfer Robert WVP Bus Dev & Con Mfg05/22/201622,293
PRZYBYL ARTHURPresident and CEO04/16/201650,213
Schrepfer Robert WVP Bus Dev & Con Mfg02/18/201639,600
PRZYBYL ARTHURPresident and CEO01/08/2016104,597
Marken James G.Vice President, Operations12/18/2015151,410
PRZYBYL ARTHURPresident and CEO11/12/2015102,375
Arnold Charlotte C.Vice President and CFO09/25/2015145,038
Arnold Charlotte C.Vice President and CFO09/02/201569,498
PRZYBYL ARTHURPresident and CEO08/10/201563,600
Marken James G.Vice President, Operations07/17/201547,032
Schrepfer Robert WVP Bus Dev & Con Mfg06/18/201559,809
Arnold Charlotte C.VP and CFO05/22/201534,674
PRZYBYL ARTHURPresident and CEO05/22/201578,004
Marken James G.Vice President, Operations05/13/2015100,657
PRZYBYL ARTHURPresident and CEO05/07/201531,800
Arnold Charlotte C.VP and CFO05/06/201525,440
Schrepfer Robert WVP Bus Dev & Con Mfg05/06/201516,500
Marken James G.Vice President, Operations03/19/2015997,500
MARSHBANKS TRACYDirector03/12/2015376,614
MARSHBANKS TRACYDirector03/12/20159,041,508
MARSHBANKS TRACYDirector03/12/2015141,183
MARSHBANKS TRACYDirector03/12/20153,670,695
Arnold Charlotte C.Vice President and CFO03/12/20152,835,000
PRZYBYL ARTHURPresident and CEO03/12/20154,725,000
MERIDIAN VENTURE PARTNERS II LP10% Owner03/12/201518,900,000
RAYNOR DANIELDirector03/12/201512,600,000
MANGANO ROSS JDirector09/15/201482,477
PRZYBYL ARTHURPresident and CEO09/09/201426,500
Marken James G.Vice President, Operations06/18/2014171,400
MARSHBANKS TRACYDirector05/08/201441,455
MANGANO ROSS JDirector05/07/201460,760
MARSHBANKS TRACYDirector03/21/20141,926
MARSHBANKS TRACYDirector03/21/201449,821
MARSHBANKS TRACYDirector03/21/2014122,720
MARSHBANKS TRACYDirector03/20/20145,583
MARSHBANKS TRACYDirector03/20/2014145,466
MARSHBANKS TRACYDirector03/20/2014358,335
MERIDIAN VENTURE PARTNERS II LP10% Owner03/19/2014354,390
MERIDIAN VENTURE PARTNERS II LP10% Owner03/20/2014317,600
MARSHBANKS TRACYDirector03/18/2014502,356
MARSHBANKS TRACYDirector03/19/20141,550
MARSHBANKS TRACYDirector03/19/201440,002
MARSHBANKS TRACYDirector03/19/201498,473
MARSHBANKS TRACYDirector03/18/20147,848
MARSHBANKS TRACYDirector03/18/2014203,939
MERIDIAN VENTURE PARTNERS II LP10% Owner03/13/20141,660,368
MERIDIAN VENTURE PARTNERS II LP10% Owner03/12/20141,188,884
MERIDIAN VENTURE PARTNERS II LP10% Owner03/18/2014694,936
MERIDIAN VENTURE PARTNERS II LP10% Owner03/17/2014359,280
MERIDIAN VENTURE PARTNERS II LP10% Owner03/14/20141,008,091
RAYNOR DANIELDirector03/14/2014417,946
RAYNOR DANIELDirector03/12/2014715,556
RAYNOR DANIELDirector03/12/2014715,452
MERIDIAN VENTURE PARTNERS II LP10% Owner03/13/20141,660,683
MERIDIAN VENTURE PARTNERS II LP10% Owner03/12/20141,188,838
Arnold Charlotte C.Chief Financial Officer03/06/201473,287
Arnold Charlotte C.Chief Financial Officer03/05/201449,436
PRZYBYL ARTHURPresident and CEO03/05/2014206,298
Arnold Charlotte C.Chief Financial Officer02/25/201444,693
PRZYBYL ARTHURPresident and CEO02/25/2014185,475
PRZYBYL ARTHURPresident and CEO02/12/2014118,521
Arnold Charlotte C.Chief Financial Officer02/12/201428,641
PRZYBYL ARTHURPresident and CEO02/05/2014111,701
Arnold Charlotte C.Chief Financial Officer02/05/201427,043
PRZYBYL ARTHURPresident and CEO01/29/2014120,438
Arnold Charlotte C.Chief Financial Officer01/29/201429,083
Arnold Charlotte C.Chief Financial Officer01/22/201432,693
PRZYBYL ARTHURPresident and CEO01/22/2014135,396
PRZYBYL ARTHURPresident and CEO01/15/2014130,413
Arnold Charlotte C.Chief Financial Officer01/15/201431,489
Arnold Charlotte C.Chief Financial Officer01/08/201428,367
PRZYBYL ARTHURPresident and CEO01/08/2014117,536
Arnold Charlotte C.Chief Financial Officer01/02/201426,478
PRZYBYL ARTHURPresident and CEO01/02/2014109,561
PRZYBYL ARTHURPresident and CEO12/26/201395,439
Arnold Charlotte C.Chief Financial Officer12/26/201323,041
Arnold Charlotte C.Chief Financial Officer12/18/201320,582
PRZYBYL ARTHURPresident and CEO12/18/201385,385
Arnold Charlotte C.Chief Financial Officer12/11/201320,090
PRZYBYL ARTHURPresident and CEO12/11/201383,075
PRZYBYL ARTHURPresident and CEO12/04/201373,444
Arnold Charlotte C.Chief Financial Officer12/04/201317,754
PRZYBYL ARTHURPresident and CEO11/27/201382,357
Arnold Charlotte C.Chief Financial Officer11/27/201319,920
PRZYBYL ARTHURPresident and CEO11/22/201375,717
Arnold Charlotte C.Chief Financial Officer11/22/201318,320
PRZYBYL ARTHURPresident and CEO11/13/201363,887
Arnold Charlotte C.Chief Financial Officer11/13/201315,441
MANGANO ROSS JDirector11/07/2013101,430
Arnold Charlotte C.Chief Financial Officer11/06/201315,130
PRZYBYL ARTHURPresident and CEO11/06/201362,673
PRZYBYL ARTHURPresident and CEO10/30/201356,873
Arnold Charlotte C.Chief Financial Officer10/30/201313,735
Arnold Charlotte C.Chief Financial Officer10/23/201313,768
PRZYBYL ARTHURPresident and CEO10/23/201364,640
Arnold Charlotte C.Chief Financial Officer10/16/201314,557
PRZYBYL ARTHURPresident and CEO10/16/201360,168
PRZYBYL ARTHURPresident and CEO10/09/201356,161
Arnold Charlotte C.Chief Financial Officer10/09/201313,550
PRZYBYL ARTHURPresident and CEO10/02/201356,984
Arnold Charlotte C.Chief Financial Officer10/02/201313,768
Arnold Charlotte C.Chief Financial Officer09/25/201312,421
PRZYBYL ARTHURPresident and CEO09/25/201351,284
PRZYBYL ARTHURPresident and CEO09/18/201346,216
Arnold Charlotte C.Chief Financial Officer09/18/201311,160
Arnold Charlotte C.Chief Financial Officer09/11/20139,501
PRZYBYL ARTHURPresident and CEO09/11/201339,317
PRZYBYL ARTHURPresident and CEO09/04/201339,234
Arnold Charlotte C.Chief Financial Officer09/04/20139,488
PRZYBYL ARTHURPresident and CEO08/28/201339,875
Arnold Charlotte C.Chief Financial Officer08/28/20139,662
MANGANO ROSS JDirector08/20/201374,659
ROSENOW EDWARD C IIIDirector11/14/20117,110
SULLIVAN LOUIS WDirector08/15/201126,700
MANGANO ROSS JDirector08/12/201160,000
DONENBERG PHILIP BSr. VP of Finance, CFO & Secy08/08/20112,230
DONENBERG PHILIP BSr. VP of Finance, CFO & Secy08/05/20112,190
MANGANO ROSS JDirector08/05/2011176,800
DONENBERG PHILIP BSr. VP of Finance, CFO & Sec'y01/21/20111,880
DONENBERG PHILIP BSr. VP of Finance, CFO & Sec'y01/19/20111,880
SIMES STEPHEN MVice Chairman, President & CEO01/18/20118,849
SULLIVAN LOUIS WDirector01/13/201117,200
MANGANO ROSS JDirector12/07/201029,400
Load More Insider Transactions
FUNDS WITH A POSITION IN ANI PHARMACEUTICALS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.2,524,8930.00355%0.96%Other
GEODE CAPITAL MANAGEMENT, LLC329,6890.0019%2.6%Other
RENAISSANCE TECHNOLOGIES LLC95,5990.00816%141.4%Other
GOTHAM ASSET MANAGEMENT, LLC9,2690.00948%81.6%Other
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)6,3470.00646%NewOther
BALYASNY ASSET MANAGEMENT L.P.5,3110.00055%NewEvent Driven
AQR CAPITAL MANAGEMENT LLC4,5810.00048%NewOther
CHANGE IN SHARES OUTSTANDING FOR ANI PHARMACEUTICALS INC
STOCK BUYBACKS FOR ANI PHARMACEUTICALS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
0.95%
1Q
12/31/2023
06/30/2023
8.13%
2Q
12/31/2023
03/31/2023
16.79%
3Q
12/31/2023
12/31/2022
18.26%
4Q
12/31/2023
09/30/2022
18.43%
5Q
12/31/2023
06/30/2022
18.65%
6Q
12/31/2023
03/31/2022
19.64%
7Q
12/31/2023
12/31/2021
36.10%
8Q
12/31/2023
09/30/2021
59.47%
9Q
12/31/2023
06/30/2021
59.76%
10Q
12/31/2023
03/31/2021
60.66%
11Q
12/31/2023
12/31/2020
60.93%
12Q
12/31/2023
09/30/2020
60.85%
13Q
12/31/2023
06/30/2020
61.34%
14Q
12/31/2023
03/31/2020
62.22%
15Q
12/31/2023
12/31/2019
61.16%
16Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
0.95%
1Q
06/30/2023
8.13%
2Q
03/31/2023
16.79%
3Q
12/31/2022
18.26%
4Q
09/30/2022
18.43%
5Q
06/30/2022
18.65%
6Q
03/31/2022
19.64%
7Q
12/31/2021
36.10%
8Q
09/30/2021
59.47%
9Q
06/30/2021
59.76%
10Q
03/31/2021
60.66%
11Q
12/31/2020
60.93%
12Q
09/30/2020
60.85%
13Q
06/30/2020
61.34%
14Q
03/31/2020
62.22%
15Q
12/31/2019
61.16%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR ANI PHARMACEUTICALS INC
LOADING...